Skip to main content
. 2022 Apr 20;13:894464. doi: 10.3389/fimmu.2022.894464

Figure 1.

Figure 1

Resolution of urticarial rash after BTK inhibitor ibrutinib therapy [(A) pre-treatment; (B) post-treatment].